General Information
Revision date
2012-01-26
Product name
Novapath HIV-1 Immunoblot Reactive 2 R2
1.2.1 Relevant identified uses
In-vitro laboratory reagent or component
Emergency telephone
1(800) 424-9300
Icons in SDS
Company Information
company name
Bio-Rad Laboratories, Diagnostic Group
e-mail address of the competent person responsible for the Safety Data Sheet
TechsupportUSSD@bio-rad.com
Section 2
Additional information
For the wording of the listed risk phrases refer to section 15 · Listing of dangerous and non-hazardous components: 26628-22-8 sodium azide T+ R28 0.01-0.1% N R50/5 3 R32 * 3 Hazards identification · Classification of the substance or mixture · Classification according to Directive 67/548/EEC or Directive 1999/45/EC Xn; Harmful R22: Harmful if swallowed. R32: Contact with acids liberates very toxic gas. · Information concerning particular hazards for human and environment: not applicable · Classification system: The classification was made according to OSHA 29CFR 1910.1200 and 1910.1030, and is expanded upon from company and/or literature information. · Label elements · Labelling according to EU guidelines: The product has been classified and marked in accordance with EU Directives / Ordinance on Hazardous Materials (Contd. of page 1) · Code letter and hazard designation of product: Xn Harmful · Hazard-determining components of labelling: sodium azide · Risk phrases: 22 Harmful if swallowed. 32 Contact with acids liberates very toxic gas. · Safety phrases: 20 When using do not eat or drink. 23 Do not breathe vapour. 25 Avoid contact with eyes. 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 36/37/39 Wear suitable protective clothing, gloves and eye/face protection. · Emergency overview: · Routes of exposure: Ingestion *
